Overview
PPG Tablets 0.3 mg contain Voglibose, an oral alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus, particularly to control postprandial (after-meal) blood glucose levels. Voglibose works by slowing down carbohydrate digestion and absorption in the intestine, thereby reducing the rise in blood sugar after meals. It is typically used as an adjunct to diet, exercise, or other antidiabetic medications.





